HUP9901288A2 - LHRH-analógokat és antiösztrogéneket tartalmazó kombinációs gyógyszerkészítmények nőgyógyászati zavarok kezelésére - Google Patents

LHRH-analógokat és antiösztrogéneket tartalmazó kombinációs gyógyszerkészítmények nőgyógyászati zavarok kezelésére

Info

Publication number
HUP9901288A2
HUP9901288A2 HU9901288A HUP9901288A HUP9901288A2 HU P9901288 A2 HUP9901288 A2 HU P9901288A2 HU 9901288 A HU9901288 A HU 9901288A HU P9901288 A HUP9901288 A HU P9901288A HU P9901288 A2 HUP9901288 A2 HU P9901288A2
Authority
HU
Hungary
Prior art keywords
antiestrogens
pharmaceutical preparation
preparation containing
combined pharmaceutical
analogous substances
Prior art date
Application number
HU9901288A
Other languages
English (en)
Inventor
Peter Muhn
Klaus Stöckemann
Original Assignee
Schering Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag. filed Critical Schering Ag.
Publication of HUP9901288A2 publication Critical patent/HUP9901288A2/hu
Publication of HUP9901288A3 publication Critical patent/HUP9901288A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A találmány tárgya egy LHRH-analóg vagy LHRH-analógők kőmbinációjánakés egy szövetszelektív ösztrőgén hatású antiösztőrgénnek - melyralőxifen, drőlőxifen, centchrőmán vagy ezek származéka - alkalmazásanőgyógyászati zavarők, különösen endőmetriősisők és miómák kezelésére. ŕ
HU9901288A 1996-01-29 1997-01-29 Combined pharmaceutical preparation containing lhrh-analogous substances and antiestrogens for treating gynaecological disorders HUP9901288A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19604231A DE19604231A1 (de) 1996-01-29 1996-01-29 Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen

Publications (2)

Publication Number Publication Date
HUP9901288A2 true HUP9901288A2 (hu) 1999-08-30
HUP9901288A3 HUP9901288A3 (en) 2000-03-28

Family

ID=7784640

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901288A HUP9901288A3 (en) 1996-01-29 1997-01-29 Combined pharmaceutical preparation containing lhrh-analogous substances and antiestrogens for treating gynaecological disorders

Country Status (20)

Country Link
US (3) US7309691B2 (hu)
EP (1) EP0877621A1 (hu)
JP (1) JP2000505422A (hu)
KR (1) KR19990082080A (hu)
CN (1) CN1209750A (hu)
BG (1) BG63248B1 (hu)
BR (1) BR9707210A (hu)
CZ (1) CZ239198A3 (hu)
DE (1) DE19604231A1 (hu)
EA (1) EA001178B1 (hu)
HU (1) HUP9901288A3 (hu)
IL (1) IL125557A0 (hu)
MX (1) MX9806082A (hu)
NO (1) NO983465L (hu)
PL (1) PL328066A1 (hu)
SK (1) SK98798A3 (hu)
TR (1) TR199801452T2 (hu)
TW (1) TW577735B (hu)
WO (1) WO1997027863A1 (hu)
ZA (1) ZA97741B (hu)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105487B2 (en) 2000-10-05 2006-09-12 Veyx-Pharma Gmbh Method for inducing onset of the reproductive cycle of female breeding animals

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US6096764A (en) * 1997-08-21 2000-08-01 Eli Lilly And Company Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration
DE69912422T2 (de) * 1998-04-23 2004-08-19 Zentaris Gmbh Methode zur behandlung von fruchtbarkeitsstörungen
PT1229906E (pt) * 1999-08-31 2008-01-18 Bayer Schering Pharma Ag Mesoprogestinas para o tratamento e prevenção de distúrbios ginecológicos hormonodependentes benignos
US8193252B1 (en) 1999-08-31 2012-06-05 Bayer Pharma AG Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders
US7005418B1 (en) 1999-09-23 2006-02-28 Zentaris Gmbh Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
NZ534836A (en) * 1999-09-23 2007-07-27 Zentaris Gmbh Method for the therapeutic management of extrauterine proliferatoin of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
AU2001269439A1 (en) * 2000-07-05 2002-01-14 Takeda Chemical Industries Ltd. Medicinal preparations for treating sex hormone-dependent diseases
IL145838A (en) * 2000-10-16 2008-11-03 Pfizer Prod Inc Use of an estrogen agonist / antagonist to produce a drug for the treatment of vaginitis
WO2002056903A2 (en) * 2001-01-17 2002-07-25 Praecis Pharmaceuticals Inc. Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators
JP2003137814A (ja) * 2001-08-10 2003-05-14 Takeda Chem Ind Ltd ＧｎＲＨアゴニストの併用剤
US7705011B2 (en) 2005-03-16 2010-04-27 Masao Igarashi Agent for treatment and prevention of endometriosos and uterine adenomyosis
EP2266567A1 (en) 2009-05-26 2010-12-29 Æterna Zentaris GmbH Use of cetrorelix in combination with PDE V inhibitors for the treatment of sex hormone dependent disorders
EP2266568A1 (en) 2009-05-26 2010-12-29 Æterna Zentaris GmbH Use of LHRH antagonists in combination with PDE V inhibitors for the treatment of sex hormone dependent disorders
BR112012032189B1 (pt) * 2010-06-16 2020-11-03 Endorecherche, Inc usos de um agonista ou antagonista de lhrh em associação com um modulador de receptor de estrogênio seletivo e com um precursor de esteróide sexual para a preparação de uma medicamento para o tratamento ou prevenção de doenças relacionadas com estrogênio e kits

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
US5457116A (en) * 1993-10-15 1995-10-10 Eli Lilly And Company Methods of inhibiting uterine fibrosis
US5451589A (en) * 1993-12-21 1995-09-19 Eli Lilly And Company Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism
US5451590A (en) * 1993-12-21 1995-09-19 Eli Lilly & Co. Methods of inhibiting sexual precocity
US5593987A (en) * 1993-12-21 1997-01-14 Eli Lilly And Company Methods of inhibiting breast disorders
US6096764A (en) * 1997-08-21 2000-08-01 Eli Lilly And Company Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105487B2 (en) 2000-10-05 2006-09-12 Veyx-Pharma Gmbh Method for inducing onset of the reproductive cycle of female breeding animals

Also Published As

Publication number Publication date
CN1209750A (zh) 1999-03-03
ZA97741B (en) 1997-07-30
US20010041672A1 (en) 2001-11-15
TW577735B (en) 2004-03-01
BR9707210A (pt) 1999-04-06
US20020032156A1 (en) 2002-03-14
NO983465L (no) 1998-09-18
SK98798A3 (en) 1999-03-12
BG63248B1 (bg) 2001-07-31
IL125557A0 (en) 1999-03-12
PL328066A1 (en) 1999-01-04
NO983465D0 (no) 1998-07-28
TR199801452T2 (xx) 1998-10-21
EA199800666A1 (ru) 1999-02-25
BG102660A (en) 1999-06-30
JP2000505422A (ja) 2000-05-09
CZ239198A3 (cs) 1998-11-11
KR19990082080A (ko) 1999-11-15
WO1997027863A1 (de) 1997-08-07
US20020198155A1 (en) 2002-12-26
EP0877621A1 (de) 1998-11-18
MX9806082A (es) 1998-10-31
EA001178B1 (ru) 2000-10-30
HUP9901288A3 (en) 2000-03-28
US7309691B2 (en) 2007-12-18
DE19604231A1 (de) 1997-07-31

Similar Documents

Publication Publication Date Title
HUP9901288A2 (hu) LHRH-analógokat és antiösztrogéneket tartalmazó kombinációs gyógyszerkészítmények nőgyógyászati zavarok kezelésére
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
NO20063853L (no) Kombinasjonsterapi for osteoporose
DE69739758D1 (de) Vakzine zur behandlung von lymphomen und leukämie
TW366342B (en) The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
AP1697A (en) Azabicycloalkanes as CCR5 modulators.
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
DE60117615D1 (de) Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen
ATE185971T1 (de) Kombinationspräparat zur behandlung hypogonadaler männer sowie männern mit hypophysenerkrankungen
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
AU5861799A (en) Use of acetylcholinesterase inhibitors for the preparation of pharmaceutical compositions for the treatment of functional and/or organic pain syndromes
DE69718150D1 (de) Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
DE69501419T2 (de) Pharmazeutische Zusammensetzung zur Behandlung von Osteoporose enthaltend Xanthohumol
ATE229338T1 (de) 2',2'-difluornucleoside zur immunosuppressiven therapie und kombinationspräparate
DE59813162D1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
SE9604348D0 (sv) Användning av hydroxyguanidiner
DE69727240D1 (de) Kombinationen enthaltend vx478, zidovudin und 3tc zur behandlung von hiv
ATE258057T1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
HUP9802423A2 (hu) Hiperproliferatív megbetegedések kombinált gyógyászati kezelése
DE69519602D1 (de) Kugelförmige Aktivkohle zur Behandlung von Hämorrhoiden
ATE375160T1 (de) Mesoprogestine zur behandlung und vorbeugung von hormonabhängigen gutartigen gynekologischen störungen
ATE293994T1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen
AP9700928A0 (en) Pharmaceutical compositions for the prevention or treatment of retrovirus infections
DE69915852D1 (de) Lhrh-analoga zur behandlung der osteoporose